| Quarterly Financials | Mar 2011 | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 2 | 6 | 3 | 6 | 5 | 5 | 3 | 6 | 4 | 3 | 4 | 8 | 6 | 5 | 4 | 8 | 6 | 6 | 6 | 10 | 7 | 8 | 53 | 112 | 44 | 20 | 34 | 17 | 16 | 20 | 13 | 19 | 18 | 19 | 17 | 22 | 20 | 27 | 23 | 33 | 28 | 27 | 27 |
| Expenses | 2 | 6 | 3 | 5 | 4 | 4 | 2 | 5 | 4 | 3 | 3 | 6 | 4 | 4 | 3 | 6 | 4 | 4 | 3 | 7 | 5 | 4 | 17 | 32 | 18 | 10 | 15 | 9 | 7 | 13 | 7 | 8 | 7 | 11 | 8 | 11 | 9 | 13 | 9 | 13 | 10 | 15 | 10 |
| EBITDA | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 37 | 80 | 27 | 10 | 20 | 8 | 9 | 8 | 6 | 11 | 10 | 9 | 9 | 11 | 12 | 14 | 15 | 20 | 18 | 13 | 16 |
| Operating Profit % | 16 % | 2 % | 6 % | 10 % | 12 % | 5 % | 16 % | 19 % | 12 % | 16 % | 26 % | 23 % | 21 % | 24 % | 34 % | 23 % | 32 % | 38 % | 39 % | 25 % | 34 % | 35 % | 69 % | 71 % | 58 % | 45 % | 56 % | 39 % | 49 % | 32 % | 44 % | 53 % | 50 % | 41 % | 45 % | 41 % | 50 % | 43 % | 56 % | 56 % | 59 % | 35 % | 53 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 1 | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 36 | 80 | 26 | 10 | 20 | 8 | 8 | 8 | 6 | 11 | 10 | 8 | 9 | 10 | 11 | 14 | 14 | 19 | 18 | 13 | 16 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 9 | 20 | 7 | 2 | 5 | 2 | 2 | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 3 | 5 | 3 | 4 | 4 | 5 | 3 |
| Net Profit | -0 | -0 | -0 | 0 | 0 | -0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 27 | 60 | 20 | 7 | 15 | 6 | 7 | 5 | 5 | 8 | 8 | 5 | 7 | 8 | 9 | 9 | 11 | 15 | 14 | 8 | 13 |
| EPS in ₹ | 0.00 | -0.39 | -0.15 | 0.47 | 0.42 | -0.39 | 0.06 | 1.11 | 0.30 | 0.15 | 1.04 | 2.07 | 1.32 | 0.91 | 1.37 | 2.39 | 2.48 | 1.94 | 1.89 | 3.00 | 2.31 | 3.02 | 36.22 | 79.56 | 26.20 | 9.47 | 19.89 | 6.84 | 8.74 | 6.43 | 6.28 | 9.70 | 9.00 | 6.94 | 8.41 | 8.86 | 9.94 | 10.26 | 13.19 | 17.35 | 15.75 | 9.38 | 14.76 |
3B BlackBio DX
3B BlackBio DX
1,378.00
+7.10
(0.52%)
Key Fundamentals
Market Cap
1,176.60 Cr
EPS
55.66
PE Ratio
24.27
Dividend Yield
0.29 %
Industry
Healthcare Services 52 Week High
2,350.00
52 Week Low
1,291.50
PB Ratio
4.43
Debt to Equity
0.00
Sector
Healthcare Service Provider Actual
Company News
View All News
3B BlackBio Dx Limited Approves Key Board Appointments at 53rd AGMSep 27, 2025
3B BlackBio Dx Limited held its 53rd Annual General Meeting on September 26, 2025, where members approved several key appointments. Mrs. Mithla Dubey, aged 78, was re-appointed as director after retiring by rotation. Mr. Praveen Kumar Rai of P.K. Rai and Associates was appointed as Secretarial Auditor for five consecutive years from FY 2025-26 to FY 2029-30. Mr. Dhirendra Dubey was re-appointed as Chairman-cum-Managing Director for five years from November 30, 2025 to November 29, 2030. Mr. Vivek Saihgal was appointed as Independent Director for five years from August 14, 2025 to August 13, 2030. Mrs. Mithla Dubey is the mother of Chairman-cum-Managing Director Mr. Dhirendra Dubey and serves as a woman director to comply with regulatory requirements. Mr. Vivek Saihgal, aged 65, brings 45 years of managerial experience in logistics, ports, and terminals, and has worked with organizations including Shipping Corporation of India and Tata Consultancy Services.
3B BlackBio Dx Reports 18% Revenue Growth in Q1 FY26, Acquires Belgium-Based Coris Bioconcept
Aug 23, 2025
Aug 23, 20253B BlackBio Dx Limited reported Q1 FY26 sales of ₹19.96 crores, representing an 18% year-on-year increase from ₹16.94 crores. EBITDA grew 11% to ₹16.19 crores. The company acquired Coris Bioconcept, a Belgium-based rapid diagnostics company, for up to £4.765 million. The company holds a 12-15% market share in India's molecular diagnostics market and expects 15-20% growth in FY26, outpacing the industry's projected 8-10% growth. Domestic business is expected to grow 15-20% while export business is targeted for 20-25% growth. The company aims to increase exports from the current 17-18% to 35-40% of total revenue within five years. EBITDA margins are approximately 60% for core business, expected to trend towards 55% due to competition. Current capacity utilization stands at 65% with no major capital expenditure required for the next 2-3 years.
3B BlackBio Dx Limited approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The company reported standalone revenue from operations of Rs 2,035.71 lakhs and profit after tax of Rs 1,246.04 lakhs, with earnings per share of Rs 14.54. On a consolidated basis, revenue from operations was Rs 2,223.46 lakhs with profit after tax of Rs 1,264.45 lakhs. The Board approved the reappointment of Mr. Dhirendra Dubey as Chairman and Managing Director for five years effective November 30, 2025, and appointed Mr. Vivek Saihgal as an Independent Director for five years from August 14, 2025. The company also reappointed M/s Sanjay Kasliwal & Associates as Cost Auditor for FY 2025-26. Other expenses for the quarter included one-time M&A advisory fees of Rs 84.06 lakhs for the acquisition of Coris Bioconcept SRL, Belgium.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,108.10 | #1 26,445.40 | 50.26 | #1 2,554.80 | 11.28 | #1 492 | 24.30 | 43.79 | |
992.05 | 10,295.10 | 67.60 | 699.70 | 23.06 | 144 | 22.54 | 42.12 | |
1,938.20 | 10,103.00 | 65.93 | 1,346.30 | 10.64 | 146 | 18.90 | 38.21 | |
1,243.90 | 6,760.50 | 52.12 | 702.20 | 20.80 | 91 | 81.06 | 51.86 | |
779.10 | 2,643.10 | 31.52 | 742.70 | 16.70 | 78 | 14.53 | 40.44 | |
300.55 | 1,563.20 | 48.21 | 255.90 | 15.11 | 31 | 19.48 | 49.29 | |
1,378.00 | #7 1,176.60 | #3 24.27 | #9 111.60 | #2 28.72 | #6 48 | #8 11.50 | 43.85 | |
305.30 | 986.10 | #1 -6.49 | 1,170.80 | -18.47 | -134 | -35.12 | 49.51 | |
261.00 | 503.60 | 19.21 | 147.80 | #1 134.60 | 19 | #1 444.44 | 44.37 | |
163.30 | 117.60 | 76.21 | 41.80 | 13.28 | 2 | 0.00 | 31.57 |
Growth Rate
Revenue Growth
28.72 %
Net Income Growth
48.60 %
Cash Flow Change
60.89 %
ROE
23.60 %
ROCE
19.97 %
EBITDA Margin (Avg.)
11.27 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 25 | 24 | 26 | 30 | 36 | 45 | 194 | 192 | 214 | 248 | 296 |
| Fixed Assets | 4 | 3 | 3 | 4 | 4 | 4 | 5 | 7 | 8 | 7 | 7 |
| Current Assets | 21 | 21 | 22 | 26 | 32 | 39 | 118 | 82 | 114 | 123 | 132 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 59 | 93 | 92 | 117 | 156 |
| Other Assets | 21 | 21 | 22 | 27 | 32 | 40 | 130 | 93 | 115 | 123 | 132 |
| Total Liabilities | 25 | 24 | 26 | 30 | 36 | 45 | 194 | 192 | 214 | 248 | 296 |
| Current Liabilities | 12 | 10 | 11 | 9 | 10 | 8 | 43 | 17 | 14 | 18 | 19 |
| Non Current Liabilities | 3 | 3 | 4 | 3 | 3 | 2 | 2 | 3 | 4 | 5 | 6 |
| Total Equity | 10 | 10 | 11 | 19 | 23 | 34 | 148 | 172 | 196 | 226 | 271 |
| Reserve & Surplus | 4 | 4 | 5 | 12 | 16 | 25 | 125 | 146 | 185 | 215 | 260 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 8 | 8 | 8 | 9 | 9 | 9 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | 1 | 2 | 7 | 26 | -6 | 30 | 3 | 7 |
| Investing Activities | 0 | 0 | -0 | -1 | -1 | -1 | -70 | -28 | 15 | -20 | -34 |
| Operating Activities | 0 | 1 | 1 | 2 | 4 | 7 | 98 | 37 | 20 | 27 | 43 |
| Financing Activities | -0 | -1 | -0 | 0 | -1 | 1 | -2 | -15 | -5 | -4 | -3 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Feb 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 38.35 % | 38.35 % | 38.35 % | 38.43 % | 38.43 % | 38.43 % | 38.43 % | 38.43 % | 38.43 % | 38.43 % | 38.43 % | 38.43 % | 41.29 % | 41.29 % | 41.29 % | 41.29 % | 41.29 % | 41.28 % | 41.28 % | 41.28 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 3.38 % | 2.97 % | 2.97 % | 3.28 % | 3.27 % | 2.68 % | 2.49 % | 2.70 % | 2.64 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.18 % | 1.89 % | 1.89 % | 1.96 % | 1.96 % | 1.74 % | 1.60 % | 1.76 % | 1.82 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 46.71 % | 44.60 % | 46.97 % | 44.76 % | 44.77 % | 45.68 % | 45.66 % | 46.47 % | 45.71 % | 45.34 % | 43.38 % | 43.01 % | 41.94 % | 41.94 % | 42.22 % | 42.41 % | 42.80 % | 43.31 % | 43.17 % | 43.53 % |
| Others | 14.94 % | 17.05 % | 14.68 % | 16.81 % | 16.80 % | 15.89 % | 15.91 % | 15.11 % | 15.86 % | 16.23 % | 18.19 % | 13.99 % | 11.92 % | 11.92 % | 11.26 % | 11.07 % | 11.49 % | 11.32 % | 11.09 % | 10.73 % |
| No of Share Holders | 0 | 9,772 | 10,541 | 16,251 | 16,756 | 16,468 | 16,316 | 15,415 | 13,798 | 12,416 | 10,513 | 10,088 | 9,753 | 9,753 | 9,399 | 9,586 | 10,166 | 10,345 | 10,619 | 10,709 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.3 | 0.5 | 0.5 | 0.7 | 9 | 10.5 | 2.5 | 3 | 4 |
| Dividend Yield (%) | 0.00 | 0.22 | 0.66 | 0.69 | 0.25 | 2.64 | 2.62 | 0.32 | 0.19 | 0.29 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 16 Sept 2021 |  Dividend | ₹ 8.00 /share | 14 Sept 2021 | 452.10 | 527.65 |
| 16 Sept 2021 | Dividend | ₹ 1.00 /share | 14 Sept 2021 | 452.10 | 527.65 |
| 05 Aug 2022 |  Extraordinary General Meeting | NA | 05 Aug 2022 | 310.20 | 314.85 |
| 16 Sept 2022 | Dividend | ₹ 2.50 /share | 14 Sept 2022 | 338.85 | 350.70 |
| 15 Sept 2023 | Dividend | ₹ 2.50 /share | 15 Sept 2023 | 433.00 | 810.15 |
| 16 Nov 2023 |  Change Of Name | NA | 16 Nov 2023 | 715.50 | 715.50 |
| 18 Sept 2024 | Dividend | ₹ 3.00 /share | 17 Sept 2024 | 793.35 | 1,427.40 |
| 24 Sept 2024 |  Annual General Meeting | NA | 24 Sept 2024 | 1,480.45 | 1,354.90 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 1,456.10 | 1,411.40 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 1,844.90 | 1,732.95 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 1,704.95 | 1,970.20 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 1,581.05 | 1,631.95 |
| 19 Sept 2025 | Dividend | ₹ 4.00 /share | 19 Sept 2025 | 1,970.20 | 1,398.70 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 1,449.25 | 1,382.35 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
3 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 30, 2025
Sep 30, 2025Appointment Of Secretarial Auditor.Sep 27, 2025
Sep 27, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 27, 2025
Sep 27, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 20, 2025
Sep 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 13, 2025
Sep 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Sep 05, 2025Letters To ShareholdersSep 04, 2025
Sep 04, 2025 53Rd Annual General Meeting On Friday 26Th September 2025Sep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesSep 04, 2025
Sep 04, 2025Record Date And Date Of Book Closure For The Purpose Of Dividend And AGMSep 04, 2025
Sep 04, 2025Reg. 34 (1) Annual Report.Sep 04, 2025
Sep 04, 2025Notice Of 53Rd Annual General MeetingSep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 01, 2025
Sep 01, 2025Disclosure Under Regulation 30 Of SEBI (LODR)Regulations 2015Sep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 25, 2025
Aug 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 23, 2025
Aug 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 19, 2025
Aug 19, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 14, 2025
Aug 14, 2025Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On 30Th June 2025Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Aug 13, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The First Quarter Ended 30Th June2025.Aug 06, 2025
Aug 06, 2025Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Jul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-DemiseJul 15, 2025
Jul 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.
Jul 01, 2025
Jul 01, 2025Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Jun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended 31-03-2025Jun 14, 2025
Jun 14, 2025Newspaper PublicatiobJun 04, 2025
Jun 04, 2025Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)Jun 03, 2025
Jun 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2025
May 29, 2025Appointment Of Secretarial AuditorMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 28, 2025
May 28, 2025Board Meeting Outcome for Outcome Of Board Meeting Dt 28-05-2025May 28, 2025
May 28, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter / Financial Year Ended March 31 2025 And To Discuss The Matter Of Recommendation Of Dividend If Any For The Financial Year Ended March 31 2025May 19, 2025
May 19, 2025Intimation To The Holders Of Physical Securities To Furnish KYC DetailsMay 12, 2025
May 12, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Apr 30, 2025
Apr 30, 2025Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 15, 2025
Apr 15, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 11, 2025
Apr 11, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.05% | 67 | 0.05% | 0.05% |
Technical Indicators
RSI(14)
Neutral 45.97
ATR(14)
Less Volatile 42.79
STOCH(9,6)
Neutral 29.46
STOCH RSI(14)
Neutral 37.28
MACD(12,26)
Bullish 1.16
ADX(14)
Strong Trend 30.93
UO(9)
Bearish 40.61
ROC(12)
Uptrend And Accelerating 0.87
WillR(14)
Neutral -46.36
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
